MedTrace Logo

Screening Evaluation for Studies of Chronic Obstructive Pulmonary Disease (COPD)

NCT00889447 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 670

Last updated 2018-03-12

No results posted yet for this study

Summary

This research is being done to study mechanisms of progression of COPD and to develop treatments for it. The investigators are doing the present study to identify people age 40 and older with mild to moderate COPD who will qualify for such studies to include in a database. The study will include establishing a screening evaluation or characterization of the following two studies:

* Emphysema Progression in COPD- Losartan's Effects on Airway Parameters - NA\_00009980
* Sleep-Related Physiology and Inflammation in Chronic Obstructive Pulmonary Disease - NA\_00001771

Conditions

Sponsors & Collaborators

Principal Investigators

  • Gregory Diette, MD,MHS · Johns Hopkins University

Eligibility

Min Age
40 Years
Max Age
100 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-01-31
Primary Completion
2017-05-31
Completion
2017-05-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00889447 on ClinicalTrials.gov